Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 186 clinical trials
Study of Oral Venetoclax Tablets to Evaluate Adverse Events and Change in Disease Activity in Participants Above 19 Years of Age With Acute Myeloid Leukemia (AML)

venetoclax is in participants with AML . Adverse events and change in disease activity will be monitored under routine clinical practice. Venetoclax is an approved drug for treatment of Acute Myeloid

cancer
venetoclax
  • 0 views
  • 10 Apr, 2022
  • 1 location
Venetoclax Registry (VENreg)

Registry Study on Patient Characteristics, Biological Disease Profile and Clinical Course in the Treatment of Acute Myeloid Leukemia With Venetoclax

venetoclax
refractory acute myeloid leukemia (aml)
  • 3 views
  • 13 Feb, 2022
  • 1 location
Venetoclax Resistance Landscape in Chronic Lymphocytic Leukemia (RAVEN)

The purpose of this study is to collect medical informations and samples from refractory and/or relapsed chronic lymphocytic leukemia during or after venetoclax treatment, in order to evaluate

richter syndrome
chronic lymphocytic leukemia
venetoclax
  • 0 views
  • 21 Apr, 2022
  • 1 location
Pharmacokinetics of Venetoclax in Patients With Acute Myeloid Leukemia

Venetoclax is a treatment for chronic lymphocytic leukemia (CLL) and acute myeloid leukemia (AML). However, the pharmacokinetic data in Chinese population, as well as the change of venetoclax

cancer
venetoclax
  • 0 views
  • 03 Nov, 2021
  • 1 location
Pharmacokinetics of Venetoclax in Patients With Chronic Lymphocytic Leukemia

Venetoclax is a treatment for chronic lymphocytic leukemia (CLL) and acute myeloid leukemia (AML). However, the pharmacokinetic data in Chinese population, as well as the change of venetoclax

cancer
venetoclax
chronic lymphocytic leukemia
  • 0 views
  • 03 Nov, 2021
  • 1 location
Observational Study Relapsed or Refractory Chronic Lymphocytic Leukemia Venetoclax-based Regimens Outside Clinical Trials in Italy

Observational study aimed at describing the characteristics and outcome of CLL patients who started treatment with venetoclax-based regimens according to the local label outside clinical trials

chronic lymphocytic leukemia refractory
lymphoid leukemia
chronic lymphocytic leukemia
venetoclax
  • 0 views
  • 21 Mar, 2022
  • 23 locations
Study Venetoclax Effectiveness and Real-Life Treatment Management in Participants With Chronic Lymphocytic Leukemia (VERONE)

This study will evaluate real-life effectiveness and use in participants starting venetoclax treatment for Chronic Lymphocytic Leukemia (CLL).

lymphoid leukemia
venetoclax
chronic lymphocytic leukemia
  • 21 views
  • 04 Jun, 2022
  • 58 locations
A Study of Clinical Outcomes in Chronic Lymphocytic Leukemia (CLL) Patients Treated With Venetoclax in Greece

This study is being done to evaluate the clinical outcomes of Chronic Lymphocytic Leukemia (CLL) participants treated with venetoclax as routine standard of care in Greece. The decision to treat

chronic lymphocytic leukemia refractory
lymphoid leukemia
chronic lymphocytic leukemia
venetoclax
  • 2 views
  • 06 Jul, 2022
  • 19 locations
A Study to Describe the Safety and Effectiveness of Venetoclax in Acute Myeloid Leukemia (AML) Patients (REVIVE Study) (REVIVE)

This study will describe the safety and effectiveness of venetoclax in AML patients in routine clinical practice in Israel. The decision to treat with venetoclax is made by the physician prior

venetoclax
  • 6 views
  • 18 May, 2022
  • 11 locations
Study of the Use of Venetoclax in Participants With Chronic Lymphocytic Leukemia (CLL) Under Real-Life Setting

An observational study to assess the effectiveness, health economic-relevant costs and participant reported outcomes in participants with Chronic lymphocytic leukemia (CLL) receiving venetoclax

venetoclax
rituximab
obinutuzumab
lymphoid leukemia
chronic lymphocytic leukemia
  • 26 views
  • 01 Jul, 2022
  • 60 locations